Free tool
FAERS Monitor: Tlando
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208088 or its brand name (Tlando, Testosterone Undecanoate). Reports on generic versions are filed under their own applications.
Reports
250
Serious
208
83% of reports
Hospitalization
95
Death reported
20
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use31
- drug abuse13
- atrial fibrillation10
- drug ineffective10
- asthma9
- erectile dysfunction9
- fatigue9
- weight decreased9
- duodenal ulcer8
- erosive duodenitis8
- faeces discoloured8
- pneumonia haemophilus8
- polycythaemia8
- product use in unapproved indication8
- pyrexia8
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 2 |
| 2012 | 9 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 12 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 22 |
| 2019 | 8 |
| 2020 | 9 |
| 2021 | 14 |
| 2022 | 12 |
| 2023 | 23 |
| 2024 | 33 |
| 2025 | 42 |
| 2026 | 30 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,909 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pneumonia haemophilusSignal | 8 | 1409.5 | 708.6 | 9,733 |
| erosive duodenitisSignal | 8 | 850.7 | 428.7 | 5,907 |
| polycythaemiaSignal | 8 | 327.5 | 165.4 | 2,279 |
| duodenal ulcerSignal | 8 | 95.5 | 48.3 | 656 |
| faeces discolouredSignal | 8 | 31.1 | 15.7 | 204 |
| erectile dysfunctionSignal | 9 | 29.5 | 15.5 | 220 |
| drug abuseSignal | 13 | 13.1 | 7.7 | 134 |
| atrial fibrillationSignal | 10 | 8.6 | 4.7 | 60 |
| asthmaSignal | 9 | 6.7 | 3.5 | 38 |
| off label useSignal | 31 | 3.0 | 2.1 | 40 |
| product use in unapproved indicationSignal | 8 | 2.7 | 1.4 | 7 |
| weight decreasedSignal | 9 | 2.7 | 1.4 | 8 |
| pyrexia | 8 | 1.9 | 1.0 | 3 |
| fatigue | 9 | 1.0 | 0.5 | 0 |
| drug ineffective | 10 | 0.6 | 0.3 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.